BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28744737)

  • 21. Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis.
    Poultsides GA; Huang LC; Chen Y; Visser BC; Pai RK; Jeffrey RB; Park WG; Chen AM; Kunz PL; Fisher GA; Norton JA
    Ann Surg Oncol; 2012 Jul; 19(7):2295-303. PubMed ID: 22396008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical management of advanced pancreatic neuroendocrine tumors: short-term and long-term results from an international multi-institutional study.
    Birnbaum DJ; Turrini O; Vigano L; Russolillo N; Autret A; Moutardier V; Capussotti L; Le Treut YP; Delpero JR; Hardwigsen J
    Ann Surg Oncol; 2015 Mar; 22(3):1000-7. PubMed ID: 25190116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-institutional Development and External Validation of a Nomogram Predicting Recurrence After Curative Liver Resection for Neuroendocrine Liver Metastasis.
    Xiang JX; Zhang XF; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
    Ann Surg Oncol; 2020 Oct; 27(10):3717-3726. PubMed ID: 32436187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary site surgery for elderly patients with distant metastatic pancreatic neuroendocrine tumor: to do or not to do?
    Zhang J; Peng CS; Tian YH
    Clin Interv Aging; 2019; 14():1419-1432. PubMed ID: 31496669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Outcomes of Surgical Management of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases.
    Partelli S; Inama M; Rinke A; Begum N; Valente R; Fendrich V; Tamburrino D; Keck T; Caplin ME; Bartsch D; Thirlwell C; Fusai G; Falconi M
    Neuroendocrinology; 2015; 102(1-2):68-76. PubMed ID: 26043944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is Resection of Primary Midgut Neuroendocrine Tumors in Patients with Unresectable Metastatic Liver Disease Justified? A Systematic Review and Meta-Analysis.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Kostakis ID; Moris D; Schizas D; Cloyd JM; Pawlik TM
    J Gastrointest Surg; 2019 May; 23(5):1044-1054. PubMed ID: 30671800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeat hepatectomy for patients with recurrent neuroendocrine liver metastasis: Comparison with first hepatectomy.
    Kiritani S; Arita J; Matsumura M; Nishioka Y; Kudo H; Ichida A; Ishizawa T; Akamatsu N; Kaneko J; Hasegawa K
    Surgery; 2020 Feb; 167(2):404-409. PubMed ID: 31635827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target.
    Gamboa AC; Ethun CG; Postlewait LM; Lopez-Aguiar AG; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Kooby DA; Staley CA; Cardona K; Maithel SK
    Surg Oncol; 2020 Dec; 35():460-465. PubMed ID: 33080545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical resection improves the outcome of the patients with neuroendocrine tumor liver metastases: large data from Asia.
    Du S; Wang Z; Sang X; Lu X; Zheng Y; Xu H; Xu Y; Chi T; Zhao H; Wang W; Cui Q; Zhong S; Huang J; Mao Y
    Medicine (Baltimore); 2015 Jan; 94(2):e388. PubMed ID: 25590842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas.
    Conrad C; Kutlu OC; Dasari A; Chan JA; Vauthey JN; Adams DB; Kim M; Fleming JB; Katz MH; Lee JE
    J Gastrointest Surg; 2016 Dec; 20(12):1966-1974. PubMed ID: 27714644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic micrometastases are associated with poor prognosis in patients with liver metastases from neuroendocrine tumors of the digestive tract.
    Gibson WE; Gonzalez RS; Cates JMM; Liu E; Shi C
    Hum Pathol; 2018 Sep; 79():109-115. PubMed ID: 29763717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of the preoperative main pancreatic duct dilation and neutrophil-to-lymphocyte ratio in pancreatic neuroendocrine tumors (PNETs) of the head after curative resection.
    Zhou B; Zhan C; Xiang J; Ding Y; Yan S
    BMC Endocr Disord; 2019 Nov; 19(1):123. PubMed ID: 31718651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study.
    Elias D; Lasser P; Ducreux M; Duvillard P; Ouellet JF; Dromain C; Schlumberger M; Pocard M; Boige V; Miquel C; Baudin E
    Surgery; 2003 Apr; 133(4):375-82. PubMed ID: 12717354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of Neuroendocrine Tumor Liver Metastases: Long-Term Outcomes and Prognostic Factors from a Large Prospective Database.
    Fairweather M; Swanson R; Wang J; Brais LK; Dutton T; Kulke MH; Clancy TE
    Ann Surg Oncol; 2017 Aug; 24(8):2319-2325. PubMed ID: 28303430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors.
    Sherman SK; Maxwell JE; Carr JC; Wang D; Bellizzi AM; Sue O'Dorisio M; O'Dorisio TM; Howe JR
    Clin Exp Metastasis; 2014 Dec; 31(8):935-44. PubMed ID: 25241033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcomes following 90Y Radioembolization of neuroendocrine liver metastases: evaluation of the radiation-emitting SIR-spheres in non-resectable liver tumor (RESiN) registry.
    Wong TY; Zhang KS; Gandhi RT; Collins ZS; O'Hara R; Wang EA; Vaheesan K; Matsuoka L; Sze DY; Kennedy AS; Brown DB
    BMC Cancer; 2022 Mar; 22(1):224. PubMed ID: 35232410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life after treatment of neuroendocrine liver metastasis.
    Spolverato G; Bagante F; Wagner D; Buettner S; Gupta R; Kim Y; Maqsood H; Pawlik TM
    J Surg Res; 2015 Sep; 198(1):155-64. PubMed ID: 26095419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
    Zheng M; Li Y; Li T; Zhang L; Zhou L
    Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological features and prognosis factors for survival in elderly patients with pancreatic neuroendocrine tumor: A STROBE-compliant article.
    Li G; Tian ML; Bing YT; Tao LY; Wang HY; Jiang B; Yuan CH; Xiu DR
    Medicine (Baltimore); 2019 Mar; 98(11):e14576. PubMed ID: 30882623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The First Case Report of Robotic Multivisceral Resection for Synchronous Liver Metastasis from Pancreatic Neuroendocrine Tumor: A Case Report and Literature Review.
    Calin ML; Sadiq A; Arevalo G; Fuentes R; Flanders VL; Gupta N; Nasri B; Singh K
    J Laparoendosc Adv Surg Tech A; 2016 Oct; 26(10):816-824. PubMed ID: 27454160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.